NATAP (National AIDS Treatment Advocacy Project)
Edit Page
Report
Scan day: 20 February 2014 UTC
0
Virus safety - good
Description: Reports on the latest HIV drug treatments, therapies, and conferences.
—
Size: 0 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
Page title: | National AIDS Treatment Advocacy Project - NATAP - HIV - AIDS Treatment Information |
Keywords: | protease inhibitors, HIV, AIDS, treatment, Hep C, hepatitis, Hepatitis C, HCV, coinfection, co-infection, IVDU, peg-intron, Interferon, liver, Ribavirin, Pegylated Interferon, Pegasys, genotype, experimental, nucleosides, non-nucleosides, drug therapies, HIV drugs, adherence, compliance, viral load, 50 copies, proviral DNA, RNA, 4 drugs, Efavirenz, DMP-266, salvage therapy, 1592U89, Abacavir, t-20, fusion inhibitor, PMEA, MKC-442, resistance, double protease, Crixivan, indinavir, Viracept, nelfinavir, Saquinavir, Invirase, d4T, Zerit, AZT, retrovir, ddI, Videx, abuse, information, biomedical, clinical, national, infectious, science, resources, std, retrovirus, 580 Broadway, Suite 1010, Jules Levin, women, NATAP, ritonavir, norvir, Viramune, Epivir, 3TC, studies, virus, cocktails, New York, biomedical, abuse, research, gay, minorities, health, disease, education, hepatitis B, HCV, HBV, liver, liver transplantation job, employment |
Description: | Natap's web site is a leader in up-to-the minute HIV treatment information, covering the latest in drug development and research, comprehensive conference reports, and in-depth articles on HIV treatments. NATAP's newsletter, Protease Inhibitor User's Guide, and other publications are all available on the site |
IP-address: | 216.92.100.202 |